BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30559911)

  • 1. Pharmacist assessment to prevent inadvertent prohibited substance use among competitive strength athletes.
    Smith-Morris AD; Lien K; Arnold BE
    Can Pharm J (Ott); 2018; 151(6):372-376. PubMed ID: 30559911
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacists supporting athletes: a scoping review exploring the knowledge, role and responsibilities of pharmacists in preventing the unintentional use of prohibited substances by athletes.
    Greenbaum DH; McLachlan AJ; Roubin RH; Chaar BB
    Int J Pharm Pract; 2022 May; 30(2):108-115. PubMed ID: 35262700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining pharmacists' anti-doping knowledge and skills in assisting athletes to avoid unintentional use of prohibited substances.
    Greenbaum DH; McLachlan AJ; Roubin RH; Moles R; Chaar BB
    Int J Pharm Pract; 2023 May; 31(3):290-297. PubMed ID: 36869840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of the role of the sports pharmacist with a model for the prediction of athletes' actions to cope with sickness].
    Yamaguchi T; Horio I; Aoki R; Yamashita N; Tanaka M; Izushi F; Miyauchi Y; Araki H
    Yakugaku Zasshi; 2013; 133(11):1249-59. PubMed ID: 24189566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review.
    McDuff D; Stull T; Castaldelli-Maia JM; Hitchcock ME; Hainline B; Reardon CL
    Br J Sports Med; 2019 Jun; 53(12):754-760. PubMed ID: 31097457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Why Did the Sports Pharmacists Create the Card Game?].
    Shimizu M
    Yakugaku Zasshi; 2022; 142(2):115-121. PubMed ID: 35110446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
    Di Luigi L; Pigozzi F; Sgrò P; Frati L; Di Gianfrancesco A; Cappa M
    J Endocrinol Invest; 2020 May; 43(5):563-573. PubMed ID: 31734891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexually transmitted doping: The impact of urine contamination of semen.
    Handelsman DJ; Bacha F; DeBono M; Sleiman S; Janu MR
    Drug Test Anal; 2022 Sep; 14(9):1623-1628. PubMed ID: 35655428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary Supplements: A Gateway to Doping?
    Mallick M; Camacho CB; Daher J; El Khoury D
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using response-time latencies to measure athletes' doping attitudes: the brief implicit attitude test identifies substance abuse in bodybuilders.
    Brand R; Wolff W; Thieme D
    Subst Abuse Treat Prev Policy; 2014 Sep; 9():36. PubMed ID: 25209168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ophthalmic drug therapy in professional athletes-what is allowed, what is doping?].
    Wall K; Rokohl AC; Scheiff AB; Katlun T; Heindl LM
    Ophthalmologie; 2022 Dec; 119(12):1250-1256. PubMed ID: 35947154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Dietary Supplements a Gateway to Doping? A Retrospective Survey of Athletes' Substance Use.
    Hurst P
    Subst Use Misuse; 2023; 58(3):365-370. PubMed ID: 36645808
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. London 2012: prescribing for athletes in ophthalmology.
    Nicholson RG; Thomas GP; Potter MJ; Norris JH
    Eye (Lond); 2012 Aug; 26(8):1036-8. PubMed ID: 22744394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadriceps strength is an early indicator of return to competitive sports 1 year after anterior cruciate ligament reconstruction in adult amateur athletes.
    Murakami R; Fukai A; Yoshitomi H; Honda E; Sanada T; Iwaso H
    Eur J Orthop Surg Traumatol; 2023 Feb; 33(2):361-366. PubMed ID: 34988722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of High-Repetition Strength Training on Performance in Competitive Endurance Athletes: A Systematic Review and Meta-Analysis.
    Nugent FJ; Flanagan EP; Darragh I; Daly L; Warrington GD
    J Strength Cond Res; 2023 Jun; 37(6):1315-1326. PubMed ID: 37235540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship of Anthropometric and Physical Performance Characteristics on Competitive Success in Amateur, Elite, and Professional Rodeo Athletes.
    Oranchuk DJ; Gullett LK; Kicia M; Thome B; Game A
    J Strength Cond Res; 2023 Jul; 37(7):1495-1506. PubMed ID: 37129597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.